Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fu L Luan

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Transplantation|June 4, 2002
Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacyFu L Luan, Minoru Hojo, Mary Maluccio, et al.
Transplantation|August 12, 2011
Early pancreas graft failure is associated with inferior late clinical outcomes after simultaneous kidney-pancreas transplantationSilas P Norman, Mallika Kommareddi, Akinlolu O Ojo, et al.
Clinical Transplants|June 1, 2013
Incidences of preformed and de novo donor-specific HLA antibodies and their clinicohistological correlates in the early course of kidney transplantationYihung Huang, Daniel Ramon, Fu L Luan, et al.
Transactions of the American Clinical and Climatological Association|September 22, 2009
Post-transplantation malignancy: a cell autonomous mechanism with implications for therapyManikkam Suthanthiran, Minoru Hojo, Mary Maluccio, et al.
Transplantation|August 24, 2007
Impact of simultaneous pancreas and kidney transplantation on cardiovascular risk factors in patients with type 1 diabetes mellitusFu L Luan, Clifford D Miles, Diane M Cibrik, et al.
Clinical Transplantation|October 19, 2011
The time interval between kidney and pancreas transplantation and the clinical outcomes of pancreas after kidney transplantationFu L Luan, Mallika Kommareddi, Diane M Cibrik, et al.
Journal of the American Society of Nephrology : JASN|September 19, 2009
Six-month prophylaxis is cost effective in transplant patients at high risk for cytomegalovirus infectionFu L Luan, Linda J Stuckey, Jeong M Park, et al.
Kidney International|March 13, 2003
Rapamycin is an effective inhibitor of human renal cancer metastasisFu L Luan, Ruchuang Ding, Vijay K Sharma, et al.
Transplantation|January 22, 2009
A pilot study of gene expression-based categorization of pancreas transplant biopsiesFu L Luan, Fabian Trillsch, Anna Henger, et al.
Proteomics. Clinical Applications|December 11, 2013
Identification of a protein signature in renal allograft rejectionDiane M Cibrik, Roscoe L Warner, Mallika Kommareddi, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Transplantation|June 4, 2002
Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacyFu L Luan, Minoru Hojo, Mary Maluccio, et al.
Transplantation|August 12, 2011
Early pancreas graft failure is associated with inferior late clinical outcomes after simultaneous kidney-pancreas transplantationSilas P Norman, Mallika Kommareddi, Akinlolu O Ojo, et al.
Clinical Transplants|June 1, 2013
Incidences of preformed and de novo donor-specific HLA antibodies and their clinicohistological correlates in the early course of kidney transplantationYihung Huang, Daniel Ramon, Fu L Luan, et al.
Transactions of the American Clinical and Climatological Association|September 22, 2009
Post-transplantation malignancy: a cell autonomous mechanism with implications for therapyManikkam Suthanthiran, Minoru Hojo, Mary Maluccio, et al.
Transplantation|August 24, 2007
Impact of simultaneous pancreas and kidney transplantation on cardiovascular risk factors in patients with type 1 diabetes mellitusFu L Luan, Clifford D Miles, Diane M Cibrik, et al.
Clinical Transplantation|October 19, 2011
The time interval between kidney and pancreas transplantation and the clinical outcomes of pancreas after kidney transplantationFu L Luan, Mallika Kommareddi, Diane M Cibrik, et al.
Journal of the American Society of Nephrology : JASN|September 19, 2009
Six-month prophylaxis is cost effective in transplant patients at high risk for cytomegalovirus infectionFu L Luan, Linda J Stuckey, Jeong M Park, et al.
Kidney International|March 13, 2003
Rapamycin is an effective inhibitor of human renal cancer metastasisFu L Luan, Ruchuang Ding, Vijay K Sharma, et al.
Transplantation|January 22, 2009
A pilot study of gene expression-based categorization of pancreas transplant biopsiesFu L Luan, Fabian Trillsch, Anna Henger, et al.
Proteomics. Clinical Applications|December 11, 2013
Identification of a protein signature in renal allograft rejectionDiane M Cibrik, Roscoe L Warner, Mallika Kommareddi, et al.
Pageof 3